谷歌浏览器插件
订阅小程序
在清言上使用

1598P Xaluritamig, a STEAP1 X CD3 XmAb 2+1 Immune Therapy, in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc): Initial Results from Dose Expansion Cohorts in a Phase I Study

W.K. Kelly,L.J. Appleman, C-C. Lin, A.J. Armstrong, S.C. Fischer,D.W. Pook,J.L. Perez Gracia, J.L. Lee,D.R. Berthold, P.J. Ward,D.E. Castellano Gauna,L.G. Horvath, M. Kim, N. Matsubara,C. Sumey, M. Shabooti, Z. Yang,J. Connarn, J. Stieglmaier,D.C. Danila

Annals of Oncology(2024)

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要